ESG risk score -
Environmental score -
Social score -
Governance score -
ESG risk category -
Negligible Low Med High Severe
0-10 10-20 20-30 30-40 40+
Hemab Therapeutics Holdings Inc
000.00
0.00 / 0.00%
00:00:00
52 week range
0000.00 000.00
Symbol COAG:xnas
Currency USD
NASDAQ
Open Closed
15 minutes delayed
Data provided by 
This information is not currently available for this instrument. Refresh the page or try again later.
Want to start investing?
Trade stocks with a broker trusted by over 1.5 million clients. Investing involves risk. You may lose some or all of your investment.
Chart
This information is not currently available for this instrument. Refresh the page or try again later.
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer.
Quotes
- Bid
- Ask
- Open
- Previous close
- Volume
- Relative volume
- High
- Low
This information is not currently available for this instrument. Refresh the page or try again later.
Returns
Year to date (YTD) -
1 year -
3 years -
Data provided by 
Key stats
Price/earnings (LTM) -
Dividend yield (LTM) -
EPS (LTM) -0.81
Volatility (30 days) 117.75%
Data provided by
Analyst consensus
Average rating Buy
Rating Analysts
Buy
5
Overweight
0
Hold
0
Underweight
0
Sell
0
Target price 50
Implied return 1.24%
Last updated 16-Jun-2026
Data provided by
ESG risk
ESG risk is a measure of how well a company manages material ESG risks. Sustainalytics’ ESG risk category is designed to help investors identify and understand financially material ESG risks at the company level and how they might affect the long-term performance for equity investments. The scale is from 0-100. The lower the risk, the better (0 is equivalent to no risk and 100 the most severe).
Download ESG risk methodology (PDF)Data provided by 
/ 
/ Financials
Q1 Q2 Q3 Q4
Income statement
Revenue XXXXXXX XXXXXXX XXXXXXX XXXXXXX
EBITDA XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Net income XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Balance sheet
Total assets XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Total debt XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Ratios
Price/sales XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Earnings per share XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Dividend per share XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Return on equity XXXXXXX XXXXXXX XXXXXXX XXXXXXX
About Hemab Therapeutics Holdings Inc
Hemab Therapeutics Holdings Inc is a clinical-stage biotechnology company developing therapies for the treatment of blood coagulation disorders. It focuses on discovering, developing, and commercializing treatments for conditions such as Glanzmann thrombasthenia, Factor VII deficiency, and von Willebrand disease. Its flagship candidate, sutacimig (HMB-001), is a bispecific antibody currently in clinical trials for the prophylactic treatment of Glanzmann thrombasthenia and Factor VII deficiency. The company has one operating segment, engaged in the research and development of prophylactic therapeutics for bleeding disorders.
Sector Healthcare
Industry -
Market cap 2bn
Data provided by /
/ Others were interested in
This information is not currently available for this instrument. Refresh the page or try again later.
Frequently asked questions
To buy Hemab Therapeutics Holdings Inc stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Hemab Therapeutics Holdings Inc by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Hemab Therapeutics Holdings Inc is COAG. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Hemab Therapeutics Holdings Inc has its primary listing on NASDAQ. You can trade Hemab Therapeutics Holdings Inc with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Hemab Therapeutics Holdings Inc is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Hemab Therapeutics Holdings Inc as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like Hemab Therapeutics Holdings Inc or others.